Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-003345
Filing Date
2020-02-05
Accepted
2020-02-05 07:01:32
Documents
72
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyme-10q_20191231.htm 10-Q 1516720
2 EX-31.1 tyme-ex311_6.htm EX-31.1 12496
3 EX-31.2 tyme-ex312_8.htm EX-31.2 12486
4 EX-32.1 tyme-ex321_7.htm EX-32.1 8333
  Complete submission text file 0001564590-20-003345.txt   5915373

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tyme-20191231.xml EX-101.INS 1215253
6 XBRL TAXONOMY EXTENSION SCHEMA tyme-20191231.xsd EX-101.SCH 61515
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20191231_cal.xml EX-101.CAL 35795
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20191231_def.xml EX-101.DEF 167983
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20191231_lab.xml EX-101.LAB 393956
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20191231_pre.xml EX-101.PRE 312978
Mailing Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38169 | Film No.: 20576348
SIC: 2834 Pharmaceutical Preparations